Abstract
erbB-2 is a growth factor receptor gene, and it's product, p185, has tyrosine kinase activity and can transform NIH3T3 cell when overexpressed. erbB-2 oncogene has been reported to be amplified frequently in various human tumors of epithelial origin, such as breast, ovary and stomach. In breast cancer, the amplification and overexpression of erbB-2 protein, p185, have been implicated as parameters for prognosis. In this study, we analyzed 72 primary breast tumors obtained from Korean patients for gene amplification and mRNA over-expression, and 114 tumor tissue sections from paraffin blocks were analyzed for p185 expression using anti-p185 antibody. Ten (13.9%) of 72 DNA samples from primary breast tumors contained multiple copies of erbB-2 gene, ranging from 2 to 27. RNAs were prepared from 23 tumors among 72 tumors, of which 4 (17.4%) had increased amount of erbB-2 mRNA. Thirty-eight percent (43 of 114) of paraffin-embedded tissue sections were strongly reactive to the anti-p185 polyclonal antibody. No p185 was detectable in 37% ( 42 of 114) sections and the rest were weakly stained. Seventy percent (7 of 10) of tumors containing amplified erbB-2 gene were positive for p185 expression. B.ut, 37% (20 of 54) of tumors with single gene copy were strongly reactive to anti-p185 antibody. These results could explain the higher rate of protein expression than gene amplification of erbB-2 in primary breast tumors. We also observed mRNA over-expression in 2 of 15 tumors with single copy erbB-2 gene, and furthermore, strong expression of p185 protein in 4 of 15 tumors without increased mRNA expresseion. These suggest that other mechanisms than gene amplification andlor mRNA over-expression for the over-production of p185 in primary breast tumors may exist.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Joh, Jw., Noh, DY., Bae, CD. et al. Amplification and over-expression of erbB-2 oncogene in primary human breast tumors. Exp Mol Med 28, 47–53 (1996). https://doi.org/10.1038/emm.1996.8
Published:
Issue Date:
DOI: https://doi.org/10.1038/emm.1996.8
Keywords
This article is cited by
-
HER-2/neu overexpression is an independent prognostic factor in colorectal cancer
International Journal of Colorectal Disease (2007)
-
HER-2/neu Amplification Is an Independent Prognostic Factor in Gastric Cancer
Digestive Diseases and Sciences (2006)